Novak B, Milcinski M, Grmek M, Kocmur M.
Clinical Trial, Phase I 2005; 26(6): 685-689 PubMed PMID: 16380684 Keywords: Adult, Antipsychotic Agents:therapeutic use, Benzodiazepines:therapeutic use, Brain Mapping, Cerebrovascular Circulation:drug effects, Cysteine:analogs & derivatives, Frontal Lobe:blood supply, Humans, Male, Middle Aged, Organotechnetium Compounds, Psychi. CitationOBJECTIVES: Altered regional cerebral blood flow (r-CBF) is mentioned as one of possible etiological factors or as a consequence of schizo.....
Novak B, Milcinski M, Grmek M, Kocmur M. Early effects of treatment on regional cerebral blood flow in first episode schizophrenia patients evaluated with 99Tc-ECD-SPECT. Neuro Endocrinol Lett. 2005 Dec; 26(6): 685-689
Prasko J, Houbová P, Novák T, Záleský R, Espa-Cervená K, Pasková B, Vyskocilová J.
Clinical Trial 2005; 26(6): 667-674 PubMed PMID: 16380683 Keywords: Adult, Agoraphobia:complications, Alprazolam:therapeutic use, Anti-Anxiety Agents:therapeutic use, Cognitive Therapy, Combined Modality Therapy, Female, Follow-Up Studies, Humans, Male, Middle Aged, Panic Disorder:complications, Paroxetine:therapeutic use. CitationUNLABELLED: Most clinicians tend to believe that the occurrence of the anxiety disorder in comorbidity with a personality disorder often l.....
Prasko J, Houbová P, Novák T, Záleský R, Espa-Cervená K, Pasková B, Vyskocilová J. Influence of personality disorder on the treatment of panic disorder--comparison study. Neuro Endocrinol Lett. 2005 Dec; 26(6): 667-674
Prasko J, Horácek J, Záleský R, Kopecek M, Novák T, Pasková B, Skrdlantová L, Belohlávek O, Höschl C.
Clinical Trial 2004; 25(5): 340-348 PubMed PMID: 15580167 Keywords: Adult, Antidepressive Agents:therapeutic use, Brain Mapping, Cerebral Cortex:diagnostic imaging, Cognitive Therapy, Female, Fluorodeoxyglucose F18, Functional Laterality, Humans, Male, Neuropsychological Tests, Panic Disorder:diagnostic imaging, Positron-. CitationBACKGROUND: The goal of our study was to identify brain structures in patients with panic disorder (PD) that show changes in 18FDG PET dur.....
Prasko J, Horácek J, Záleský R, Kopecek M, Novák T, Pasková B, Skrdlantová L, Belohlávek O, Höschl C. The change of regional brain metabolism (18FDG PET) in panic disorder during the treatment with cognitive behavioral therapy or antidepressants. Neuro Endocrinol Lett. 2004 Oct; 25(5): 340-348
Filippi P, Vestenická V, Siarnik P, Sivakova M, Čopíková-Cudráková D, Belan V, Hanes J, Novák M, Kollar B, Turcani P.
Journal Article 2020; 41(1): 17-26 PubMed PMID: 32305054 CitationBACKGROUND: Neurofilament light chain (NfL) is considered a major marker of neurodegeneration and disease activity. Higher levels .....
Filippi P, Vestenická V, Siarnik P, Sivakova M, Čopíková-Cudráková D, Belan V, Hanes J, Novák M, Kollar B, Turcani P. Neurofilament light chain and MRI volume parameters as markers of neurodegeneration in multiple sclerosis Neuro Endocrinol Lett. 2020 Apr; 41(1): 17-26
Filippi P, Vestenická V, Siarnik P, Sivakova M, Čopíková-Cudráková D, Belan V, Hanes J, Novák M, Kollar B, Turcani P.
Journal Article 2020; 41(1): 17-26 PubMed PMID: 32338853 CitationBACKGROUND: Neurofilament light chain (NfL) is considered a major marker of neurodegeneration and disease activity. Higher levels of NfL a.....
Filippi P, Vestenická V, Siarnik P, Sivakova M, Čopíková-Cudráková D, Belan V, Hanes J, Novák M, Kollar B, Turcani P. Neurofilament light chain and MRI volume parameters as markers of neurodegeneration in multiple sclerosis. Neuro Endocrinol Lett. 2020 Apr; 41(1): 17-26